ASCENDIS PHARMA A S's ticker is and the CUSIP is 04351P951. A total of 5 filers reported holding ASCENDIS PHARMA A S in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,341,000 | +4.9% | 25,000 | 0.0% | 0.00% | – |
| Q2 2023 | $2,231,250 | -50.4% | 25,000 | -7.4% | 0.00% | -100.0% |
| Q4 2020 | $4,503,000 | -10.1% | 27,000 | -25.0% | 0.00% | 0.0% |
| Q4 2019 | $5,008,000 | -51.7% | 36,000 | -59.1% | 0.00% | -50.0% |
| Q1 2019 | $10,358,000 | +476.7% | 88,000 | +225.9% | 0.00% | – |
| Q2 2018 | $1,796,000 | – | 27,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JANE STREET GROUP, LLC | 36,800 | $3,421,000 | 0.00% |
| GROUP ONE TRADING, L.P. | 7,500 | $697,000 | 0.00% |
| SIMPLEX TRADING, LLC | 3,600 | $334,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |